Dysregulation of serum miR-1204 and its potential as a biomarker for the diagnosis and prognosis of breast cancer
Authors:
Open Access
- 1 June 2020
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 66 (6) , 732-736
Abstract
SUMMARY OBJECTIVE A previous study has reported that miR-1204 exerted oncogenic effects in breast cancer (BC). The purpose of our paper was to evaluate the expressions of tissue and serum miR-1204 in patients with BC and further investigate its biomarker potential. METHODS The expressions of tissue and serum miR-1204 were investigated by qRT-PCR in 144 BC patients and 38 healthy controls. Chi-square tests were conducted to examine the associations between miR-1204 expressions and clinicopathological factors. Then, the associations of miR-1204s level with the survival of BC patients were determined by performing the Kaplan-Meier and multivariate analysis. The receiver operating characteristics (ROC) and area under the OC curve (AUC) were obtained to validate the diagnostic values of miR-1204. RESULTS We found that the expressions of miR-1204 were increased in both tissue and serum samples from BC patients. Multivariate assays identified tissue and serum miR-1204 overexpression as an independent poor prognostic factor. In addition, ROC curve assays indicated that tissue and serum miR-1204 are potential diagnostic markers of BC. CONCLUSIONS Detection of tissue and serum miR-1204 levels could have clinical potential as a novel prognostic/diagnostic biomarker for BC patients.Keywords
This publication has 9 references indexed in Scilit:
- miR-1204 targets VDR to promotes epithelial-mesenchymal transition and metastasis in breast cancerOncogene, 2018
- Cancer treatment and survivorship statistics, 2016CA: A Cancer Journal for Clinicians, 2016
- MiR-373 drives the epithelial-to-mesenchymal transition and metastasis via the miR-373-TXNIP-HIF1α-TWIST signaling axis in breast cancerOncotarget, 2015
- Strategies to Antagonize miRNA Functions In Vitro and In VivoNanomedicine, 2014
- Increased Circulating MicroRNA-155 as a Potential Biomarker for Breast Cancer Screening: A Meta-AnalysisMolecules, 2014
- Breast Cancer: Major Risk Factors and Recent Developments in TreatmentAsian Pacific Journal of Cancer Prevention, 2014
- Identification of new p53 target microRNAs by bioinformatics and functional analysisBMC Cancer, 2013
- Breast cancer screening and the changing population pyramid of JapanBreast Cancer, 2013
- Circulating microRNAs as Specific Biomarkers for Breast Cancer DetectionPLOS ONE, 2013